Insider trade

Petmed Express (PETS): CFO had shares withheld for tax 3,246 shares

Douglas Krulik, CFO at Petmed Express, reported a tax withholding of 3,246 shares.

3,246
Shares · @ $2.65
Traded
Sep 27, 2025
Filed
Nov 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 1, 2025Insider10% owner purchased ~$379K of PETS shares in the open market
  2. Aug 13, 2025Insider10% owner purchased ~$320K of PETS shares in the open market
  3. Sep 8, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 8, 2025, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”) approved an initial annual base salary of $550,000 for Leslie C.G. Campbell, who began serving as the Company’s Interim Chief Executive Officer and President on August 11, 2025.”

What came next

  1. Oct 1, 2025Company filing · Form 8-K · Impairment, RestatementWrote down the value of assets, and said past financial statements can no longer be relied on (and 1 more item)“On October 1, 2025, the Audit Committee of the Board of Directors (the “Audit Committee”) of PetMed Express, Inc. (the “Company”), upon the recommendation of the Company’s management, concluded that a $1.2 million non-cash impairment of the Company’s PCRX trade name is required to be recorded in the quarter ended March 31, 2025.”
  2. Oct 14, 2025Company filing · Form 8-K · ResultsReported its results
  3. Oct 19, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 19, 2025, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”), appointed James LaCamp to serve as a director of the Company effective immediately.”
  4. Nov 12, 2025Company filing · Form 8-K · Results, Listing noticeReceived a notice from its stock exchange, and reported its results“On November 12, 2025, the Company received an expected notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), which indicated that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 (the “Q2 10-Q”), in addition to its continued delinquency in filing its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025…”
  5. Nov 26, 2025Company filing · Form 8-K · Material agreement, Shareholder rightsChanged a top executive or board member, and signed an important agreement (and 2 more items)“On November 26, 2025, the Board unanimously approved, upon the recommendation of the Board’s Compensation and Human Capital Committee, an increase in the annual base salary of Douglas Krulik, the Company’s Interim Principal Financial Officer and Chief Accounting Officer, from $300,000 to $330,000 per year, with such increase being deemed to be effective as of August 30, 2025.”
  6. Dec 8, 2025Company filing · Form 8-K · Auditor changeChanged its auditor“On December 8, 2025, the Audit Committee of the Board of Directors (the “Audit Committee”) of PetMed Express, Inc. (the “Company”), following a competitive process to determine the Company’s independent registered public accounting firm for the fiscal year ended March 31, 2026, approved the engagement of Baker Tilly US, LLP (“Baker Tilly”) to serve as the Company’s independent registered public accounting firm for…”
  7. Dec 8, 2025Company filing · Form 8-K · Auditor changeChanged its auditor“On December 19, 2025, the Company filed, and RSM completed its interim review of, the Company’s Quarterly Reports on Form 10-Q for the three months ended June 30, 2025, and September 30, 2025.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Petmed Express

For Petmed Express, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PETS page.

How this filing works

Explore the data

Common questions

Which Petmed Express (PETS) insider traded, and how much?

Douglas Krulik, CFO at Petmed Express, reported a tax withholding of 3,246 shares. At $2.65.

When did it happen, and when was it made public?

Traded: Sep 27, 2025. Filed: Nov 6, 2026. That is 405 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Petmed Express recently?

For Petmed Express, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the PETS page.

Does this mean PETS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Petmed Express

Everything OQRO holds on this company is on its PETS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data